The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies

The Portuguese Severe Asthma Registry (Registo de Asma Grave Portugal, RAG) was developed by an open collaborative network of asthma specialists. RAG collects data from adults and pediatric severe asthma patients that despite treatment optimization and adequate management of comorbidities require step 4/5 treatment according to GINA recommendations. In this paper, we describe the development and implementation of RAG, its features, and data sharing policies. The contents and structure of RAG were defined in a multistep consensus process. A pilot version was pretested and iteratively improved. The selection of data elements for RAG considered other severe asthma registries, aiming at characterizing the patient's clinical status whilst avoiding overloading the standard workflow of the clinical appointment. Features of RAG include automatic assessment of eligibility, easy data input, and exportable data in natural language that can be pasted directly in patients' electronic health record and security features to enable data sharing (among researchers and with other international databases) without compromising patients' confidentiality. RAG is a national web-based disease registry of severe asthma patients, available at asmagrave.pt. It allows prospective clinical data collection, promotes standardized care and collaborative clinical research, and may contribute to inform evidence-based healthcare policies for severe asthma.

[1]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .

[2]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[3]  Sally Green,et al.  Clinical practice guidelines: a guide to better practice, not a recipe for uniformity. , 2003, The Australian journal of physiotherapy.

[4]  A. Gulsvik,et al.  The socio‐economic burden of asthma is substantial in Europe , 2007, Allergy.

[5]  Nancy A Dreyer,et al.  Registries for robust evidence. , 2009, JAMA.

[6]  C. Brightling,et al.  Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry , 2010, Thorax.

[7]  N. Dreyer,et al.  Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .

[8]  J. Bousquet,et al.  Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time , 2012, Clinical and Translational Allergy.

[9]  R. Buhl,et al.  Das Register „Schweres Asthma“ , 2012, Pneumologie.

[10]  C. Brightling,et al.  Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry , 2012, Thorax.

[11]  S. Korn,et al.  [The German severe asthma registry]. , 2012, Pneumologie.

[12]  Tiago Jacinto,et al.  Prevalence of asthma in Portugal - The Portuguese National Asthma Survey , 2012, Clinical and Translational Allergy.

[13]  K. Bergmann,et al.  The German severe asthma register , 2012 .

[14]  J. F. Medina,et al.  Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[15]  Dear Mr Sotiropoulos ARTICLE 29 Data Protection Working Party , 2013 .

[16]  A. Rowe,et al.  Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. , 2013, Chest.

[17]  N. Thomson,et al.  Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. , 2013, The Journal of allergy and clinical immunology.

[18]  C. Picado,et al.  Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[19]  J. Fonseca,et al.  Validation of Control of Allergic Rhinitis and Asthma Test for Children (CARATKids) – a prospective multicenter study , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[20]  N. Thomson,et al.  The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry , 2014, Thorax.

[21]  O. Vandenplas,et al.  Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). , 2014, Respiratory medicine.

[22]  P. Burton,et al.  Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability , 2014, PloS one.

[23]  J. Fonseca,et al.  Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal. , 2015, Revista portuguesa de pneumologia.

[24]  Are asthma patients willing to participate in an interactive web-based disease registry? , 2016 .

[25]  D. Price,et al.  Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry , 2016, Thorax.

[26]  N. Thomson,et al.  Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma. , 2016, Respiratory medicine.

[27]  J. Soriano,et al.  The ERS Research Agency: the beginning , 2016, European Respiratory Journal.

[28]  Belgian Severe Asthma Registry. Which Biotherapy to Choose According to Inflammatory Characteristics , 2017 .

[29]  Role and challenges of severe asthma services: insights from the UK registry. , 2017, Minerva medica.

[30]  Procedural and short-term safety of bronchial thermoplasty in clinical practice: evidence from a national registry and Hospital Episode Statistics , 2017, The Journal of asthma : official journal of the Association for the Care of Asthma.

[31]  G. Canonica,et al.  SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma , 2017, Clinical and Molecular Allergy.

[32]  W. Busse,et al.  Care pathways for the selection of a biologic in severe asthma , 2017, European Respiratory Journal.

[33]  J. Drazen,et al.  New Biologics for Asthma. , 2018, The New England journal of medicine.

[34]  K. Samitas,et al.  An algorithmic approach for the treatment of severe uncontrolled asthma , 2018, ERJ Open Research.